INTRODUCTION
The eighth component of complement (C8)"2 is an unusual component of the complement system in that it has a three-chain structure organized in two subunits, C8a--y and C8,f, which are held together by noncovalent bonds (1) . The binding site for both the cell-bound and the fluid phase trimolecular complex C567 is situated on the fl-chain (2, 3) . The two subunits can be separated by gel filtration in the presence of sodium dodecyl sulfate (SDS) and urea and then recombined to form hemolytically active C8 (4).
The serum from some patients with C8 deficiency does not react with specific antiserum to human C8 to produce a precipitin line in immunodiffusion analysis. These sera are thought to completely lack the C8 molecule (5) (6) (7) (8) . Other patients owe their C8 deficiency to a dysfunctional C8 molecule that cross-reacts antigenically with C8 in the serum of normal individuals (9) (10) (11) (12) (13) . Analysis of these dysfunctional C8 molecules has established that they lack the C8f3-chain (11, 12, 14) . C8 deficiency due to the selective absence of the a-y-subunit has not been recognized previously. In this report, we present our findings that mixing the two different types of C8-deficient sera restores hemolytic activity to the mixture. Additional experiments confirm that C8-deficient serum which fails to react with a specific antiserum to C8 under standard conditions does, in fact, contain C8#l-subunit but lacks the C8a-'y-subunit.
METHODS
Sera. Sera from seven unrelated C8-deficient subjects were examined in this study. Detailed analysis carried out previously on each of these sera permitted the distinction between one group of four sera (group 1) with dysfunctional C8 (9, 11, 13 ) and a second group of three sera (group 2) with antigenically undetectable C8 (5, 6, 8) . All the four sera of group 1 have been shown to contain abnormal C8 consisting only of the a-y-subunit (11, 14) . Normal human serum (NHS) was obtained from healthy blood donors. All sera were stored in small aliquots in liquid nitrogen.
Complement reagents and hemolytic assay. Using the procedure described by Steckel et al. (4) , human C8 and the C8a--y-and C8i3-subunits were purified from 200 g of paste of Cohn fractions I, II, and III obtained from Instituto Sieroterapico Milanese, Milan, Italy. The purity of the C8 preparation was confirmed by SDS-polyacrylamide gel electrophoresis (PAGE) analysis. This analysis revealed two bands of 85,000 and 62,000 D, under nonreducing conditions, and three bands of 70,000, 62,000, and 15,000 D in the presence of a reducing agent. A similar procedure was followed to ascertain the separation of C8 into the a-y-and #-subunits.
Functionally purified C9 was purchased from Cordis Laboratories, Inc., Miami, FL.
The intermediate sheep erythrocytes coated with antibody and complement components up to C7 (EAC1-7) were prepared from EAC1-3b treated with one of the C8-deficient sera (D.T.) at the dilution of 1:50, as previously described (9) . We have previously shown that the abnormal C8 molecule present in D.T. serum does not bind to EAC1-7 (14) .
In the hemolytic assay, 50 jl of EAC1-7 (1.5 X 107) were mixed with the C8-deficient sera in a final volume of 250 ,ul and incubated at 370C for 30 min. The extent of hemolysis was read spectrophotometrically at 415 nm. For some experiments, 20 units of Cordis C9 were added to the assay system as an external source of C9 which, in other instances, was provided by the C8-deficient sera themselves. Hemolytic plates containing 1% agarose (Behringwerke A.G., Marburg, West Germany), 1% EAC1-7, and 1,000 units of Cordis C9 were prepared as previously described (9) .
Antigenic evaluation of C8-deficient and NHS was carried out by double immunodiffusion in. agarose (9) . Antiserum. A specific antiserum directed against human C8 was produced in rabbits by repeated subcutaneous injections of highly purified C8 in complete Freund's adjuvant. This antiserum gave a single precipitin line against NHS on agarose plates and was found to inhibit specifically the hemolysis of EAC1-7 by NHS in hemolytic plates (9) . The IgG fraction of this antiserum, prepared by DEAE chromatography (9), was the starting material for the preparation of antibodies against the C8a--y-and C803-subunits and the F(ab')2 fragments.
Immunoprecipitation of normal and abnormal C8. Immune precipitates were prepared by mixing optimal proportions of the IgG fraction from the rabbit anti-human C8 antiserum and either NHS or the sera from C8-deficient individuals (D.T. and R.G.) in the presence of 10 Lachmann (15) . This treatment led to the formation of F(ab')2 fragments of antibodies against normal C8 or C8a-y-subunit that were precipitated by 20% Na2SO4 and dialyzed against PBS. The specificity of the F(ab')2 antiwhole C8 molecule and anti-C8a-y was confirmed by the formation of a single precipitin line in double immunodiffusion against NHS or purified C8a-'y, respectively.
After removal of the immune precipitates, the supernatants from the mixtures containing either NHS (supernatant 1) or C8-deficient serum (supernatant 2) were examined for the presence of residual antibody to C8 or to its subunits. Supernatant 1 did not give a precipitin reaction when tested against the original serum, while supernatant 2 still reacted with NHS but did not recognize either the a-y-subunit purified from normal C8 or the a--y-subunit present in the serum containing dysfunctional C8. Supernatant 2 gave only a faint precipitin line with purified C8ft, but it was able to effectively inhibit the hemolysis induced by this subunit. This-supernatant was treated with 33% saturated ammonium sulfate to precipitate the residual antibody to C8,B, which was then dialyzed against PBS. The F(ab')2 antiwhole C8 and anti-C8a-y, and the IgG anti-C8f3, prepared in this manner were used in the experiments on inhibition of hemolysis.
Inhibition of hemolysis. The specificity of the various antisera used in this study was evaluated by their ability to inhibit hemolysis of EAC1-7 upon addition of purified C8 or the a-y-and ,-subunits in the presence of Cordis C9.
Briefly, 20 units of purified C8 or optimal amounts of either C8a-'y or C8,3 were incubated for 15 min at 37°C with dilutions of the antisera, and inhibition of hemolysis was examined in the hemolytic system described above. The results of the inhibition were referred to controls in which the antisera were omitted. The specificity of the antisera was further confirmed by the ability of purified C8 or of each of the C8 subunits to restore hemolysis to samples in which inhibition of hemolysis had been induced by specific antiserum. In these experiments, the dilution of the antiserum was chosen to give 70-80% inhibition of hemolysis and twice as much C8 or its subunits were used as were present in the initial mixture.
SDS-PAGE. Human C8 purified from NHS and immune precipitates from NHS and the two C8-deficient sera (prepared as described above) were subjected to SDS-PAGE. The discontinuous gel electrophoresis system of Laemmli (16) 
RESULTS
Evaluation of the hemolytic activity of C8-deficient sera. The present investigation was prompted by our initial observation that lines of hemolysis developed in hemolytic plates between adjacent wells filled with two different types of C8-deficient sera. Confirmation of this finding came from the analysis of seven C8-deficient sera. Four of these sera (group 1) had dysfunctional C8 molecules cross-reacting with C8 in NHS, as shown in the immunodiffusion plate in Fig. 1 . Under the same experimental conditions, the three remaining C8-deficient sera (group 2) did not form a precipitin line with anti-C8 (results not shown). When sera from each of these two groups were added to adjacent wells in a hemolytic plate, a line of hemolysis developed between the wells (Fig. 1) . A hemolytic reaction occurred only between sera belonging to different groups; sera from the same group failed to initiate hemolysis.
Reconstitution of hemolytic activity of the sera by purified C8 subunits. Previous studies have shown that the C8 hemolytic activity of the sera of group 1 was restored by the addition of C8,B, but not by C8a-y (11, 14) . Thus, we directed our attention towards the characterization of the defect in the group 2 sera that apparently lacked a dysfunctional molecule as defined by immunodiffusion. The results of reconstitution experiments (Fig. 2) demonstrated that hemolytic activity could be restored to group 2 sera by the addition of C8a-,y. In contrast, the addition of as much as 15 .ug of C8# failed to restore hemolytic activity to any of these sera (results not shown). For one of the group 2 sera, the restoration of hemolytic activity by C8a-,y was not as complete as for the remaining two; further analysis of this serum was prevented by its limited supply.
Evidence for the contribution of C8a-y and C8ft
by the C8-deficient sera. Because sufficient quantities of the other sera were unavailable, this experiment and FIGURE 1 Antigenic and hemolytic analysis of C8-deficient sera. The Ouchterlony plate on the left contained 5 ul of rabbit anti-human C8 in the central well. The peripheral wells contained 40 Ml of NHS or different group 1 C8-deficient sera (1, 3, 5, 7) . The hemolytic plate on the right contained 1% EAC1-7 and 1,000 units of C9. The wells were filled with 10 ,ul of different C8-deficient sera (sera 1, 3, 5, 7-group 1; sera 2, 4, 6-group 2). Detailed analyses of these sera have been published previously: serum 1 (11), 2 (6), 3 will restore hemolysis. Similarly, when hemolysis in the mixture is inhibited by antibody to the C8a-'ysubunit, only a source of a-y-subunit (D.T. serum) will restore hemolysis. Thus, R.G. C8-deficient serum lacks the C8a-y-subunit but contains the C8#l-chain, whereas D.T. C8-deficient serum lacks the C8fl-chain but contains the C8a-,y-subunit. This conclusion is further supported by the results of SDS-PAGE of immunoprecipitates obtained from NHS and C8-deficient sera after incubation with rabbit anti-human C8 (Fig. 4) . Dose-response curve of hemolysis obtained with C8-deficient sera. Dose-response curves were established by mixing various dilutions of one of the sera with a constant volume of the other serum and evaluating the hemolytic activity of the mixtures on EAC1-7. As demonstrated in Fig. 5 , R.G. serum was the limiting reagent, since higher concentrations of it than of the D.T. serum were required to achieve a comparable degree of hemolysis.
Binding of the dysfunctional C8 molecules to EACI-7. Binding of C8#l-subunit to EAC1-7 has been clearly established (3, 14) . It (Table I) . Evaluation of the reconstituted C8 molecule by antigenic analysis. The sera of the C8-deficient subjects, D.T. and R.G., and the mixture of the two sera were examined by immunodiffusion analysis against an anti-C8 antiserum (Fig. 6) . As previously reported (13) and as shown in Fig. 1 , the precipitin line obtained with D.T. serum (well 2) presents a pattern of partial identity with that of NHS (well 1). A precipitin line cross-reacting with that of NHS was produced also by R.G. serum (well 3) that had previously been reported to lack an antigenically detectable C8 molecule (5).
The two C8 molecules of R.G. and D.T. are complementary and, when mixed (well 4), produce a C8 indistinguishable antigenically from the C8 of NHS (well 1). The assembly of a complete C8 molecule from the dysfunctional C8 molecules required that R.G. and D.T. sera be mixed at a ratio of 3 to 1. Evaluation of the reconstituted C8 molecule by column chromatography. NHS, a mixture of the two types of C8-deficient sera, and the individual C8-deficient sera were chromatographed on a Sephacryl S-200 column. The hemolytic activity in the collected fractions from each chromatographic procedure was assessed in three separate assays that detected (a) whole C8 activity; (b) whole C8 and C8a-y-subunit activity; and (c) whole C8 and C8f3-subunit activity.
Hemolytic activity in both NHS and the mixture of the two C8-deficient sera appeared as a peak with an apparent molecular weight in the 150,000 range, consistent with the reported molecular weight (151,000) for C8 (4) . This peak of hemolytic activity was the only significant activity detected in the sera and the same peak was detected in all three assay systems.
Hemolytic activity in D.T. (group 1, C8fl-subunit deficient) serum was detected only in the C8a--y-subunit assay system. It appeared as a single peak in the 90,000 plus molecular weight range, consistent with the reported molecular weight (99,000) for the C8a-y-subunit (1) . Hemolytic activity in R.G. (group 2, C8a-'y-subunit deficient) serum was detected only in the C8/3-subunit assay system. It appeared as a single peak in the <67,000-molecular weight range, consistent with the reported molecular weight (64,000) for the C8#l-subunit (4) . These results indicate that generation of hemolytic activity in the mixture of the two types of C8-deficient sera occurs as a result of the reconstitution of the whole C8 molecule rather than the sequential action of the d3-and a-'y-C8 subunits. This Molecular weight markers used were IgM (900,000), IgG (150,000), transferrin (90,000), and human serum albumin (67,000). The assay system EAC1-7 + C9 (top panel) detects only the whole C8 molecule (reported molecular weight 151,000). The assay system EAC1-7 + R.G. serum (middle panel) detects whole C8 and the C8a-'y-subunit (reported molecular weight 99,000), which is absent from R.G. serum. The assay system EAC1-7 + D.T. serum (bottom panel) detects whole C8 and the C8#-subunit (reported molecular weight 64,000), which is absent from D.T. serum.
interpretation is consistent with the reported reconstitution of functional C8 activity from purified C8 subunits (4 The reconstitution of C8 activity from the two C8-deficient sera was apparent from experiments using hemolytic plates in which lines of hemolysis developed between adjacent wells filled with two different C8-deficient sera. The only missing complement component in this system was C8, since the agarose mixture contained both EAC1-7 and C9. Since no hemolysis was observed in plates containing either C8-deficient serum alone, the development of hemolysis when they were added to adjacent wells on the same plate supports the interpretation that hemolysis results from the interaction of two factors diffusing from adjacent wells. A similar phenomenon has been reported in the reactive hemolysis system where acute phase reactant and NHS provide the source of C56 and C7, respectively (18, 19) . The appearance of lines of hemolysis does not contradict the conclusion of previous studies (5, 6, 8, 9, 11, 13) , which established the lack of hemolytic activity in these sera. This was confirmed in the present study by the absence of hemolytic rings surrounding the individual wells.
More direct evidence for the formation of active C8 in the mixture of the two C8-deficient sera was obtained from inhibition experiments with an antiserum against the whole human C8 molecule. This antiserum inhibited hemolysis of EAC1-7 induced by the addition of a mixture of the two types of C8-deficient sera. This inhibition could be reversed only by the further addition of both C8-deficient sera, thus confirming the participation of the two sera in the hemolytic process.
The nature of the two factors needed for the reconstitution of active C8 was clarified by three lines of evidence. First, the four sera (group 1) with antigenically detectable dysfunctional molecules acquire hemolytic function after the addition of C8ft purified from normal human C8 (14) , and the addition of purified C8a-"y to the three C8-deficient sera with no antigenically detectable C8 (group 2) restored hemolytic activity to these sera. Second, antibodies directed against C8a--y or C8f, selectively inhibited hemolysis of EAC1-7 by the sera of groups 1 or 2, respectively. Third, the results of the SDS-PAGE analysis indicate that the two groups of sera contain different subunits of C8; D.T. serum (group 1) contains C8a-"y-but lacks the C8#-subunit, while R.G. serum (group 2) contains C8#-but lacks the C8a-y-subunit. Thus, these experiments clearly support the separation of C8-deficient sera into two groups. In preliminary results using a different procedure, Marcus et al. (20) have recently reached a similar conclusion by showing that there are two patterns of C8 polymorphism that vary according to the source of C8-deficient sera as the revealing reagent.
The experiments concerning reconstitution of hemolysis in which one of the sera was added in constant amounts to the other serum at varying dilutions showed that the limiting reagent was R.G. serum. This serum had to be present in a fourfold greater concentration than D.T. serum in order to achieve optimal hemolysis. Because the C8 subunits are present in an equimolar ratio in the intact molecule, this result probably reflects different levels of C8,3 and C8a-y in the two C8-deficient sera with C8# being present at a lower concentration in R.G. serum with respect to C8a-"y in D.T. serum. Experimental support for this assumption requires quantitation of levels of the two subunits in the sera. Unfortunately, we were unable to quantitate these levels. However, indirect support for this interpretation is provided by the immunodiffusion analysis of these sera with an anti-C8 antiserum. A precipitin line was produced by R.G. serum when a considerably larger volume than that required for D.T. serum was used in the Ouchterlony plates. By contrast, lower volumes of R.G. serum did not give visible precipitin lines, explaining the conclusion of a previous study (5) that the C8 molecule was not detectable in this serum.
An alternative explanation might be that in the intact C8 molecule, C8, is less active immunogenically than C8a--y. If this were the case, antibody generated by immunization with whole C8 might not readily detect the C8,B-subunit in the group 2 sera but would detect the C8a-^y-subunit in group 1 sera. This explanation would not account for the finding that R.G. serum was the limiting reagent in the hemolysis reconstitution experiments. However, since this serum contains C8,B and since it is the f3-subunit that binds to C567 the limiting nature of R.G. serum might be due to the possibility that an actual C8 molecule is not formed upon mixing R.G. and D.T. serum; rather, the two subunits react sequentially to restore hemolytic activity analogous to the experiments in Table I . Under these conditions, R.G. serum would indeed be the limiting reagent. However, the observation that the mixture of R.G. and D.T. sera produce a precipitin line against anti-C8 that exhibits a pattern of complete identity with the precipitin line in NHS and the results of the chromatography experiments indicate that the C8 molecule is, in fact, immunogenically and functionally reconstituted.
In conclusion, we have documented the existence of two groups of C8-deficient subjects carrying in their sera one of the two C8 subunits, C8a-,y or C8#. We have also demonstrated that the mixture of sera from the two groups allows the reconstitution of the function and the antigenic integrity of the C8 molecule.
